• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素-1β可能是区分甲状腺癌和甲状腺炎的一个因素。

IL-1β a potential factor for discriminating between thyroid carcinoma and atrophic thyroiditis.

机构信息

LIA135 CNRS.

出版信息

Eur Cytokine Netw. 2012 Jul-Sep;23(3):101-6. doi: 10.1684/ecn.2012.0312.

DOI:10.1684/ecn.2012.0312
PMID:22995155
Abstract

Interactions between cytokines and others soluble factors (hormones, antibodies...) can play an important role in the development of thyroid pathogenesis. The purpose of the present study was to examine the possible correlation between serum cytokine concentrations, thyroid hormones (FT4 and TSH) and auto-antibodies (Tg and TPO), and their usefulness in discriminating between different thyroid conditions. In this study, we investigated serum from 115 patients affected with a variety of thyroid conditions (44 Graves' disease, 17 Hashimoto's thyroiditis, 11 atrophic thyroiditis, 28 thyroid nodular goitre and 15 papillary thyroid cancer), and 30 controls. Levels of 17 cytokines in serum samples were measured simultaneously using a multiplexed human cytokine assay. Thyroid hormones and auto-antibodies were measured using ELISA. Our study showed that IL-1β serum concentrations allow the discrimination between atrophic thyroiditis and papillary thyroid cancer groups (p = 0.027).

摘要

细胞因子与其他可溶性因子(激素、抗体等)之间的相互作用可能在甲状腺发病机制的发展中起重要作用。本研究的目的是研究血清细胞因子浓度与甲状腺激素(FT4 和 TSH)和自身抗体(Tg 和 TPO)之间的可能相关性,以及它们在区分不同甲状腺疾病中的作用。在这项研究中,我们研究了来自 115 名患有各种甲状腺疾病(44 名 Graves 病、17 名桥本甲状腺炎、11 名萎缩性甲状腺炎、28 名甲状腺结节性甲状腺肿和 15 名甲状腺乳头状癌)和 30 名对照者的血清。使用多重人类细胞因子检测法同时测量血清样本中的 17 种细胞因子的水平。使用 ELISA 法测量甲状腺激素和自身抗体。我们的研究表明,IL-1β 血清浓度可区分萎缩性甲状腺炎和甲状腺乳头状癌组(p=0.027)。

相似文献

1
IL-1β a potential factor for discriminating between thyroid carcinoma and atrophic thyroiditis.白细胞介素-1β可能是区分甲状腺癌和甲状腺炎的一个因素。
Eur Cytokine Netw. 2012 Jul-Sep;23(3):101-6. doi: 10.1684/ecn.2012.0312.
2
Down-regulation of the auto-aggressive processes in patients with hypothyroid Hashimoto's thyroiditis following substitutive treatment with L-thyroxine.用左甲状腺素替代治疗后,甲状腺功能减退性桥本甲状腺炎患者自身免疫过程受到下调。
Eur Cytokine Netw. 2009 Mar;20(1):27-32. doi: 10.1684/ecn.2009.0147.
3
Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.使用表达人促甲状腺激素(TSH)受体的细胞来测量促甲状腺抗体和TSH阻断抗体。
Acta Med Austriaca. 1996;23(1-2):52-6.
4
Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.甲状腺素对甲状腺疾病患者血清可溶性白细胞介素-2受体α水平的影响。
J Clin Pharm Ther. 2004 Apr;29(2):151-6. doi: 10.1111/j.1365-2710.2004.00547.x.
5
Hashimoto's thyroiditis following Graves' disease.格雷夫斯病后发生的桥本甲状腺炎。
Acta Med Indones. 2010 Jan;42(1):31-5.
6
Coexistence of papillary carcinoma and Hashimoto's thyroiditis.乳头状癌与桥本甲状腺炎并存。
Acta Clin Croat. 2009 Mar;48(1):9-12.
7
Carcinomatous pseudothyroiditis: a problem in differential diagnosis.癌性假甲状腺炎:鉴别诊断中的一个问题。
Can Med Assoc J. 1978 Oct 21;119(8):896-8.
8
[Behavior of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].[抗甲状腺球蛋白和抗微粒体抗体在甲状腺疾病中的表现]
Chir Ital. 1984 Aug;36(4):643-7.
9
A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure.一项关于血清甲状腺自身抗体与甲状腺功能及结构异常之间关联的人群研究。
Clin Endocrinol (Oxf). 2005 Jun;62(6):713-20. doi: 10.1111/j.1365-2265.2005.02284.x.
10
Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies.促进甲状腺生长的抗体。一类独特的促甲状腺自身抗体。
N Engl J Med. 1983 Oct 27;309(17):1028-34. doi: 10.1056/NEJM198310273091705.

引用本文的文献

1
Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.甲状腺癌微环境中的炎症成分:鉴定新型生物标志物的途径。
Adv Exp Med Biol. 2021;1350:1-31. doi: 10.1007/978-3-030-83282-7_1.
2
Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice.甲状腺癌中的白细胞介素:从基础研究到临床实践的应用。
Front Immunol. 2020 Jun 12;11:1124. doi: 10.3389/fimmu.2020.01124. eCollection 2020.
3
Immune Microenvironment of Thyroid Cancer.甲状腺癌的免疫微环境
J Cancer. 2020 Jun 8;11(16):4884-4896. doi: 10.7150/jca.44506. eCollection 2020.
4
Cytokine production of papillary thyroid carcinoma coexisting with Hashimoto's thyroiditis.与桥本甲状腺炎共存的甲状腺乳头状癌的细胞因子产生
Int J Clin Exp Pathol. 2017 Sep 1;10(9):9567-9574. eCollection 2017.
5
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition.免疫检查点抑制背景下的甲状腺癌免疫全景。
Int J Mol Sci. 2019 Aug 13;20(16):3934. doi: 10.3390/ijms20163934.
6
Pro inflammatory interleukins and thyroid function in Naswar (dipping tobacco) users: a case control study.纳斯瓦尔(嚼烟)使用者体内的促炎细胞因子与甲状腺功能:一项病例对照研究
BMC Endocr Disord. 2016 Aug 11;16(1):47. doi: 10.1186/s12902-016-0127-5.
7
The immune network in thyroid cancer.甲状腺癌中的免疫网络。
Oncoimmunology. 2016 Mar 30;5(6):e1168556. doi: 10.1080/2162402X.2016.1168556. eCollection 2016 Jun.
8
Association between a functional insertion/deletion polymorphism in IL1A gene and risk of papillary thyroid carcinoma.白细胞介素1A基因功能性插入/缺失多态性与甲状腺乳头状癌风险之间的关联。
Tumour Biol. 2014 Apr;35(4):3861-5. doi: 10.1007/s13277-013-1512-6. Epub 2014 Jan 23.